IRF7 and breast cancer: Additionally, MDA-MB-453 breast cancer cells that are practically devoid of p53 protein showed a similar response to Teniposide as MDA-MB-231, in activating the NMI-619 luciferase reporter, NMI and IRF7 transcript levels (Supplementary Fig. 4A, B, and C).